Peroxiredoxin 3 has a crucial role in the contractile function of skeletal muscle by regulating mitochondrial homeostasis

Free Radical Biology and Medicine

Volumn 77, Issue , 2014, Pages 298-306

  Lee, Kwang Pyo ^a   Shin, Yeo Jin ^a,b   Cho, Sung Chun ^c   Lee, Seung Min ^a   Bahn, Young Jae ^a   Kim, Ji Young ^a   Kwon, Eun Soo ^a   Jeong, Do Yeun ^a,b   Park, Sang Chul ^c   Rhee, Sue Goo ^d   Woo, Hyun Ae ^e   Kwon, Ki Sun ^a,b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b University of Science and Technology (UST)   (South Korea)

^c SAMSUNG Electronics   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e Ewha Womans University   (South Korea)

Author keywords

Fatigue; Free radicals; Mitochondria; Mitofusin; Myoblast; Myogenesis; Oxidative stress; Peroxiredoxin 3; Reactive oxygen species; Skeletal muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; FIS1 PROTEIN; MESSENGER RNA; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MITOFUSIN 1; MITOFUSIN 2; MYOGENIN; MYOSIN HEAVY CHAIN; OPA1 PROTEIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 5; PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; GUANOSINE TRIPHOSPHATASE; HOMEODOMAIN PROTEIN; MFN1 PROTEIN, MOUSE; MFN2 PROTEIN, MOUSE; SHOX2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA CONTENT; EXTENSOR DIGITORUM LONGUS MUSCLE; GRIP STRENGTH; HOMEOSTASIS; MOUSE; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE FIBER MEMBRANE POTENTIAL; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; MUSCLE MITOCHONDRION; MUSCLE STRENGTH; MYOTUBE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SKELETAL MUSCLE; SKELETAL MYOBLAST; SOLEUS MUSCLE; WILD TYPE MOUSE; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; KNOCKOUT MOUSE; METABOLISM; MYOBLAST; PHYSIOLOGY; ULTRASTRUCTURE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA, MITOCHONDRIAL; GTP PHOSPHOHYDROLASES; HOMEODOMAIN PROTEINS; HOMEOSTASIS; MICE, KNOCKOUT; MITOCHONDRIA, MUSCLE; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; REACTIVE OXYGEN SPECIES;

EID: 84927597957     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2014.09.010     Document Type: Article

References (38)

1. [1] Frontera, W.R., Hughes, V.A., Lutz, K.J., Evans, W.J., A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J. Appl. Physiol. 71 (1991), 644–650.
2. [2] Hughes, V.A., Frontera, W.R., Wood, M., Evans, W.J., Dallal, G.E., Roubenoff, R., Fiatarone Singh, M.A., Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J. Gerontol., Ser. A 56 (2001), B209–217.
3. [3] Goodpaster, B.H., Park, S.W., Harris, T.B., Kritchevsky, S.B., Nevitt, M., Schwartz, A.V., Simonsick, E.M., Tylavsky, F.A., Visser, M., Newman, A.B., The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol., Ser. A 61 (2006), 1059–1064.
4. [4] Morley, J.E., Sarcopenia: diagnosis and treatment. J. Nutr. Health Aging 12 (2008), 452–456.
5. [5] Karakelides, H., Nair, K.S., Sarcopenia of aging and its metabolic impact. Curr. Top. Dev. Biol. 68 (2005), 123–148.
6. [6] Afilalo, J., Karunananthan, S., Eisenberg, M.J., Alexander, K.P., Bergman, H., Role of frailty in patients with cardiovascular disease. Am. J. Cardiol. 103 (2009), 1616–1621.
7. [7] von Haehling, S., Morley, J.E., Anker, S.D., An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J. Cachexia Sarcopenia Muscle 1 (2010), 129–133.
8. [8] Wanagat, J., Cao, Z., Pathare, P., Aiken, J.M., Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting, and oxidative damage in sarcopenia. FASEB J 15 (2001), 322–332.
9. [9] Fulle, S., Protasi, F., Di Tano, G., Pietrangelo, T., Beltramin, A., Boncompagni, S., Vecchiet, L., Fano, G., The contribution of reactive oxygen species to sarcopenia and muscle ageing. Exp. Gerontol. 39 (2004), 17–24.
10. [10] Mansouri, A., Muller, F.L., Liu, Y., Ng, R., Faulkner, J., Hamilton, M., Richardson, A., Huang, T.T., Epstein, C.J., Van Remmen, H., Alterations in mitochondrial function, hydrogen peroxide release and oxidative damage in mouse hind-limb skeletal muscle during aging. Mech. Ageing Dev. 127 (2006), 298–306.
11. [11] Barbieri, E., Sestili, P., Reactive oxygen species in skeletal muscle signaling. J. Signal Transduction, 2012, 2012, 982794.
12. [12] Mourkioti, F., Kratsios, P., Luedde, T., Song, Y.H., Delafontaine, P., Adami, R., Parente, V., Bottinelli, R., Pasparakis, M., Rosenthal, N., Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 116 (2006), 2945–2954.
13. [13] Fulco, M., Schiltz, R.L., Iezzi, S., King, M.T., Zhao, P., Kashiwaya, Y., Hoffman, E., Veech, R.L., Sartorelli, V., Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell 12 (2003), 51–62.
14. 12 cells. Antioxid. Redox Signaling 16 (2012), 245–261.
15. [15] Buck, M., Chojkier, M., Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 15 (1996), 1753–1765.
16. [16] Messina, S., Altavilla, D., Aguennouz, M., Seminara, P., Minutoli, L., Monici, M.C., Bitto, A., Mazzeo, A., Marini, H., Squadrito, F., Vita, G., Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am. J. Pathol. 168 (2006), 918–926.
17. [17] Cox, A.G., Winterbourn, C.C., Hampton, M.B., Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem. J. 425 (2010), 313–325.
18. [18] Huh, J.Y., Kim, Y., Jeong, J., Park, J., Kim, I., Huh, K.H., Kim, Y.S., Woo, H.A., Rhee, S.G., Lee, K.J., Ha, H., Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression. Antioxid. Redox Signaling 16 (2012), 229–243.
19. [19] Ryter, S.W., Kim, H.P., Hoetzel, A., Park, J.W., Nakahira, K., Wang, X., Choi, A.M., Mechanisms of cell death in oxidative stress. Antioxid. Redox Signaling 9 (2007), 49–89.
20. [20] Simon, H.U., Haj-Yehia, A., Levi-Schaffer, F., Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (2000), 415–418.
21. [21] Circu, M.L., Aw, T.Y., Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 48 (2010), 749–762.
22. 12 myocytes. Free Radic. Biol. Med. 49 (2010), 1646–1654.
23. [23] Youle, R.J., van der Bliek, A.M., Mitochondrial fission, fusion, and stress. Science 337 (2012), 1062–1065.
24. [24] Westermann, B., Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11 (2010), 872–884.
25. [25] Chen, H., Chomyn, A., Chan, D.C., Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280 (2005), 26185–26192.
26. [26] Chen, H., Detmer, S.A., Ewald, A.J., Griffin, E.E., Fraser, S.E., Chan, D.C., Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160 (2003), 189–200.
27. [27] Chen, H., Vermulst, M., Wang, Y.E., Chomyn, A., Prolla, T.A., McCaffery, J.M., Chan, D.C., Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141 (2010), 280–289.
28. [28] Gegg, M.E., Cooper, J.M., Chau, K.Y., Rojo, M., Schapira, A.H., Taanman, J.W., Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet 19 (2010), 4861–4870.
29. [29] Tanaka, A., Cleland, M.M., Xu, S., Narendra, D.P., Suen, D.F., Karbowski, M., Youle, R.J., Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191 (2010), 1367–1380.
30. [30] Papanicolaou, K.N., Ngoh, G.A., Dabkowski, E.R., O'Connell, K.A., Ribeiro, R.F. Jr, Stanley, W.C., Walsh, K., Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart Circ. Physiol 302 (2012), H167–179.
31. [31] Schiaffino, S., Reggiani, C., Fiber types in mammalian skeletal muscles. Physiol. Rev. 91 (2011), 1447–1531.
32. [32] Lustgarten, M.S., Jang, Y.C., Liu, Y., Qi, W., Qin, Y., Dahia, P.L., Shi, Y., Bhattacharya, A., Muller, F.L., Shimizu, T., Shirasawa, T., Richardson, A., Van Remmen, H., MnSOD deficiency results in elevated oxidative stress and decreased mitochondrial function but does not lead to muscle atrophy during aging. Aging Cell 10 (2011), 493–505.
33. [33] Saraste, M., Oxidative phosphorylation at the fin de siecle. Science 283 (1999), 1488–1493.
34. [34] Schon, E.A., DiMauro, S., Hirano, M., Human mitochondrial DNA: roles of inherited and somatic mutations. Nat. Rev. Genet. 13 (2012), 878–890.
35. [35] Scarpulla, R.C., Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol. Rev. 88 (2008), 611–638.
36. [36] Reinecke, F., Smeitink, J.A., van der Westhuizen, F.H., OXPHOS gene expression and control in mitochondrial disorders. Biochim. Biophys. Acta 1792 (2009), 1113–1121.
37. [37] Rando, T.A., Blau, H.M., Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125 (1994), 1275–1287.
38. [38] Shefer, G., Yablonka-Reuveni, Z., Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells. Methods Mol. Biol. 290 (2005), 281–304.